Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Atherosclerosis. 2016 Aug 26;253:225–236. doi: 10.1016/j.atherosclerosis.2016.08.034

Table 1.

Disease-related genomics research across three NHGRI research domains. Adapted from Ref. [4].

NHGRI domain Biology of disease Science of medicine Effectiveness of healthcare
Common rubric Discovery research Clinical validation Clinical implementation
General goal Demonstrate genotype-phenotype associations Assess outcomes after using genomic information to direct clinical care Demonstrate improved healthcare with the use of genomic information
Specific examples
  • Identify persons at increased risk of disease based on their genomic variants

  • Find all variants related to given phenotype or disease

  • Characterize variation in genes known to be related to disease or treatment response

  • Characterize phenotypic variation and effect modifiers in carriers of specific variants

  • Classify patients into subgroups with differing prognosis or treatment response (molecular taxonomy)

  • Evaluate clinician and patient satisfaction with care after receipt of genomic information

  • Assess impact of reporting incidental findings on health behaviors, healthcare utilization, and psychological well-being

  • Identify causes of rare or undiagnosed diseases

  • Identify sources of infectious disease outbreaks and susceptibilities of infectious agents

  • Compare genome sequencing to enzymatic and other assays for modifiable metabolic disorders in newborns

  • Reclassify intermediate risk patients into high- and low-risk categories where differential interventions are available

  • Validate drug targets and develop improved therapeutic agents

  • Educate clinicians and patients in clinical use of genomic information

  • Develop clinical informatics systems for reporting results of genomic analyses and providing decision support

  • Evaluate impact of using genomic variant information to individualize treatment

  • Incorporate genomic information into electronic medical records that can follow patients across care systems and throughout lifespan

  • Define clinically actionable genomic variants and disseminate that information and its relevant evidence base